about
Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney agingModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsA gene-based association method for mapping traits using reference transcriptome dataPoly-omic prediction of complex traits: OmicKriging.Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analysesGenome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.Genome-wide association and functional follow-up reveals new loci for kidney functionGenetics and genomics of human ageing.Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translationWhole-genome studies identify solute carrier transporters in cellular susceptibility to paclitaxel.Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral NeuropathyIdentification of novel germline polymorphisms governing capecitabine sensitivity.Survey of the Heritability and Sparse Architecture of Gene Expression Traits across Human Tissues.Relating human genetic variation to variation in drug responses.Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function.Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.Genetic and epigenetic variants contributing to clofarabine cytotoxicity.Common variants in Mendelian kidney disease genes and their association with renal function.Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.Clinical translation of cell-based pharmacogenomic discovery.Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.Functional consequences of PRPF39 on distant genes and cisplatin sensitivity.Gene-based association study for lipid traits in diverse cohorts implicates BACE1 and SIDT2 regulation in triglyceride levels.Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics.Genetic architecture of gene expression traits across diverse populationsMultiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary functionGenetic architecture of gene expression traits across diverse populationsIntegration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicityChronic circadian misalignment results in reduced longevity and large-scale changes in gene expression in Drosophila
P50
Q21092453-F1548B1C-ED05-4B94-89D9-B553D595D57FQ27314983-EE398006-9717-46EF-8F72-8CE2F445FE09Q28608356-C91D1125-1FA1-431D-A7EC-536D894CFD86Q33812687-75469547-4A1B-4282-996A-588DED6F164BQ33825180-C02D049F-2BB1-4D26-B2C9-A249D891E377Q33960326-27C19101-CF4F-41F6-8639-58355A02CC1DQ34220999-FF283723-A044-470C-93C5-F8C5EB61333DQ34402698-8DD9E22A-A132-4A40-B1C3-3AF2E7AE5DA7Q34810063-0D380C91-7F81-41C7-B75F-5A2DD36D4FE3Q35075274-187D0071-263D-4942-92D5-E88715ED6D24Q35099987-DC455D1A-4F76-4BD6-ADEF-3CAF57EE4A4AQ35225760-E9AF9656-8FBC-4783-A7CD-E3D208B12B93Q35799841-2886866B-0DEB-438A-9948-F80A46EDDAF6Q36035404-399981F6-C357-4666-B1CD-EDC2A3477E50Q36117686-58DC38EB-F22D-4CF2-A3F6-341C75B9B5DAQ36147462-FB4E8A75-8B0C-406E-8E2B-AAD04A6325C9Q36189755-D369C129-8E02-4D43-88A2-9E7E97270F88Q36252524-5320DD4B-FFFC-4FB0-B89A-186B2D46D29FQ36545157-405388CA-C89C-4802-8A96-626467C390E6Q36714212-6E38250F-32AD-43FF-8DB2-AB27754D6685Q36873301-79787F69-ABEA-4FA0-930C-E103A292163AQ36877796-8E74D492-5CD8-4F49-9880-8DDEB6ECD0BCQ37153800-E96950FD-E5A4-4D94-93B3-ED82CBF5ED64Q37340186-888AB927-B740-46D6-8087-D64C2A2A00C8Q37729344-0EFE2052-F99E-40B5-B4F0-2DCB3F11B237Q38036524-753A6117-FE02-4F77-A643-0C5B31596FBBQ39489732-0CFE76FD-1C3D-4003-9349-FB0224FD1066Q39796533-91CADCB5-AAF3-4559-B69D-5E236F032F86Q41069172-48EE15D5-DD37-40E4-9B6B-1D85C4B0C468Q43072148-5B53BB67-C881-477E-A503-6D529F3A7AC4Q49706131-98F1AE0E-6657-4101-ABA5-D3BB109D66C2Q50313675-A20E2A21-2EB0-47E0-AC8C-4571BB4CC19BQ51436755-A71DD6F6-200E-4D86-962C-7B0B6F613426Q53200053-0B280D4B-CF6D-4D63-BE86-FDEEF5AB0C76Q55183072-A6C95FE7-B95A-4EBE-B9BE-E8F1E3A5EA68Q55451013-56E63D0A-4312-433C-8002-D3CD436564BFQ56337665-AB997C88-BA80-41A7-92BA-7F96B5794122Q58688956-932887BD-3A66-4C4C-87EE-CF261FE95F9FQ58688960-A848EF3C-D1A8-49B8-B792-6F7EB8A86732Q60918526-2139D6D3-DC26-49A9-8702-DEA3CB671F2C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Heather E Wheeler
@en
Heather E Wheeler
@es
Heather E Wheeler
@nl
Heather E Wheeler
@sl
Heather Wheeler
@fr
type
label
Heather E Wheeler
@en
Heather E Wheeler
@es
Heather E Wheeler
@nl
Heather E Wheeler
@sl
Heather Wheeler
@fr
altLabel
Heather Wheeler
@en
prefLabel
Heather E Wheeler
@en
Heather E Wheeler
@es
Heather E Wheeler
@nl
Heather E Wheeler
@sl
Heather Wheeler
@fr
P1053
I-9279-2019
P106
P21
P31
P3835
heather-wheeler2
P496
0000-0003-1365-9667